Published in
Public Library of Science, PLoS ONE, 4(15), p. e0231828, 2020
DOI: 10.1371/journal.pone.0231828
Links
Tools
Relative dose intensity over the first four weeks of lenvatinib therapy is a factor of favorable response and overall survival in patients with unresectable hepatocellular carcinoma
Journal article published in 2020 by
Sakura Kirino,
Kaoru Tsuchiya,
Masayuki Kurosaki,
Shun Kaneko 
,
Kento Inada,
Koji Yamashita,
Leona Osawa,
Yuka Hayakawa,
Shuhei Sekiguchi,
Mao Okada,
Wan Wang,
Mayu Higuchi,
Kenta Takaura,
Chiaki Maeyashiki,
Nobuharu Tamaki
and other authors.
,
Kento Inada,
Koji Yamashita,
Leona Osawa,
Yuka Hayakawa,
Shuhei Sekiguchi,
Mao Okada,
Wan Wang,
Mayu Higuchi,
Kenta Takaura,
Chiaki Maeyashiki,
Nobuharu Tamaki
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Data provided by 